ReviewJournal of clinical medicine2022
Social Determinants of Health and Impact on Screening, Prevalence, and Management of Diabetic Retinopathy in Adults: A Narrative Review.
Review in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.
- Pooled it
- Autonomous artificial intelligence increases screening and follow-up for diabetic retinopathy in youth: the ACCESS randomized control trial.Nature communications · 2024Trial
- Community pharmacist-led educational intervention to recommend ophthalmology visits for patients with diabetes: a cluster randomized controlled trial.Annals of clinical epidemiology · 2026Article
- Autonomous AI-assisted diabetic retinopathy screening at primary care is associated with increased presentation to eye care by at risk patients.NPJ digital medicine · 2026Article
- The Burden of Delayed Diabetic Retinopathy Management and Use of Artificial Intelligence-Driven Screening Tools: A Systematic Literature Review.Ophthalmology and therapy · 2026Review
- Advanced Glycation End Products and Metabolic-Mechanical Coupling in Diabetic Retinopathy.Clinical ophthalmology (Auckland, N.Z.) · 2026Review
- Machine learning versus traditional regression models for predicting diabetic retinopathy screening adherence among community-dwelling older adults with diabetes.Frontiers in endocrinology · 2026Article
- Mapping disparities in diabetic eye exam adherence using geographic information systems.PloS one · 2026Article
- Persistent disparities in diabetic retinopathy outcomes among socially deprived individuals despite treatment adherence.Eye (London, England) · 2025Article
- Diabetic Retinopathy Screening Among Federally Qualified Health Center Patients Using Point-of-Care AI: DRES-POCAI: A Trial Protocol.JAMA network open · 2025Article
- Social Determinants Associated with Diabetic Retinopathy Awareness: National Health and Nutrition Examination Survey (2005-2008).American journal of ophthalmology · 2025Article
- Assessing geographic and institutional disparities in United States diabetic eye disease clinical trials (2000-2023).Eye (London, England) · 2025Article
- Autonomous Artificial Intelligence for Diabetic Eye Disease Testing Improves Access and Equity in the Pediatric and Adult Populations: The Johns Hopkins Medicine Experience.Diabetes spectrum : a publication of the American Diabetes Association · 2025Article
- An eye on equity: faricimab-driven health equity improvements in diabetic macular oedema using a distributional cost-effectiveness analysis from a UK societal perspective.Eye (London, England) · 2024Article
- Healthcare Resource Utilization and Costs in an At-Risk Population With Diabetic Retinopathy.Translational vision science & technology · 2024Article
- The association between health literacy and screening for disease-specific complications among community-dwelling adults with diabetes.Frontiers in public health · 2024Article
- Clinical Implementation of Autonomous Artificial Intelligence Systems for Diabetic Eye Exams: Considerations for Success.Clinical diabetes : a publication of the American Diabetes Association · 2024Article
- Barriers and Enablers Influencing the Implementation of Artificial Intelligence for Diabetic Retinopathy Screening in Clinical Practice: A Scoping Review.Clinical & experimental ophthalmologyArticle
- The Relationship Between Health Insurance Status and Diabetic Retinopathy Progression.Ophthalmology scienceArticle
- Proliferative Diabetic Retinopathy Disproportionately Impacts Distressed Communities Near a Northeastern Academic Center.Ophthalmology scienceArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
Abstract
Diabetic retinal disease (DRD) is the leading cause of blindness among working-aged individuals with diabetes. In the United States, underserved and minority populations are disproportionately affected by diabetic retinopathy and other diabetes-related health outcomes. In this narrative review, we describe racial disparities in the prevalence and screening of diabetic retinopathy, as well as the wide-range of disparities associated with social determinants of health (SDOH), which include socioeconomic status, geography, health-care access, and education.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.